US presidential election, Fed interest rate decision, FIIs trading key market movers this week: Analysts 

The November 5 US presidential elections, Federal Reserve interest rate decision, trading activity of foreign investors, and the upcoming quarterly earnings from domestic firms are the major triggers that would influence sentiments in the equity market this week, analysts said.

In an eventful week ahead, a host of macroeconomic data announcements and global trends would also drive the markets, experts said.

“The upcoming week is poised to be eventful on the global front. The US presidential election on November 5 is a key focus, and the US FOMC (Federal Open Market Committee) meeting will be crucial. Geopolitical tensions and oil price movements will remain key variables as well,” said Santosh Meena, Head of Research, Swastika Investmart Ltd.

Domestically, the final phase of Q2 earnings will be critical, while foreign institutional investor (FII) behaviour will remain under close watch, Meena added.

“The outlook for the market will be guided by the US presidential election and major macroeconomic data such as HSBC India manufacturing PMI, services PMI, US Fed interest rate decision, US S&P global composite PMI, US S&P global services PMI and BoE (Bank of England) interest rate decision,” Palka Arora Chopra, Director, Master Capital Services Ltd, said.

Leading stock exchanges BSE and NSE conducted a one-hour special ‘Muhurat Trading’ session on the occasion of Diwali on November 1, marking the start of the new Samvat 2081.

Last week, the BSE benchmark climbed 321.83 points, or 0.40 per cent.

“This week, investors’ attention will be on developments in the US markets, especially the upcoming elections on November 5 and the Federal Reserve’s policy meeting,” said Ajit Mishra — SVP, Research, Religare Broking Ltd.

“On the domestic front, earnings reports from key companies, including Dr Reddy’s, Titan, Tata Steel, M&M and Tata Motors will be in focus. Additionally, the release of key economic indicators, such as the HSBC manufacturing PMI and services PMI, will provide insight into the country’s economic momentum,” Mishra said.

Relentless selling by FIIs last month contributed hugely to the over 7 per cent decline in benchmark indices from their all-time peaks.

“Global markets will respond to the US presidential elections for a few days, after which fundamentals like US GDP growth, inflation and rate cut by the Fed will influence market moves,” said V K Vijayakumar,

 » Read More

Related Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of

Q3FY25: Mankind Pharma’s revenue up by 24 percent to Rs 3,230 Crore; Profit at Rs 380 crore

Pharma major Mankind Pharma on Thursday reported its financial results for the third quarter and nine months ended 31 st December 2024. The company reported revenue from Operations at Rs. 3,230 Cr, up by 24% YoY and domestic revenue at INR 2,773 Cr, up 17%, Exports at INR 457 Cr, up 121% YoY. The company’s